CDK Associates, LLC, 10% Owner at Kala Pharmaceuticals, Inc. (KALA), bought 763,755 shares at $15.00 ($3.2M) on 2017-07-20, disclosed to the SEC on 2017-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 548,755 | $0 | 0.0% |
| 2 | $15.00 | 215,000 | $3.2M | 100.0% |
| Total | $4.22 avg | 763,755 | $3.2M | 100% |